A detailed history of Frank, Rimerman Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 49,984 shares of OGN stock, worth $791,746. This represents 0.07% of its overall portfolio holdings.

Number of Shares
49,984
Previous 50,047 0.13%
Holding current value
$791,746
Previous $1.04 Million 7.63%
% of portfolio
0.07%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$18.65 - $23.03 $1,174 - $1,450
-63 Reduced 0.13%
49,984 $956,000
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $871,941 - $1.1 Million
49,968 Added 63250.63%
50,047 $1.04 Million
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $865 - $1,368
79 New
79 $1.14 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.03B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.